TuHURA Biosciences names Amanda Garofalo SVP of Clinical Operations

TuHURA Biosciences, Inc. +15.82% Pre

TuHURA Biosciences, Inc.

HURA

2.27

2.24

+15.82%

-1.37% Pre
  • TuHURA Biosciences named Amanda Garofalo senior vice president of clinical operations.
  • Garofalo will work with Craig Tendler and run day-to-day clinical operations.
  • She joins from Parabilis Medicines, where she supported enrollment, data-readiness, and due diligence tied to a privately funded USD 305 million Series F round.
  • Garofalo previously led oncology clinical delivery and patient centricity at EMD Serono, overseeing more than 200 oncology Phase I-IV trials.
  • TuHURA said her remit will support execution across IFx-2.0 Phase 3, TBS-2025 Phase 1b/2 planning, and preclinical work for antibody-drug conjugates.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tuhura Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA27852) on April 07, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.